TORONTO, Dec. 27, 2017
/CNW/ - Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l
Designation: PRMCF) ("Cronos" or the "Company") is pleased to
announce that its first shipment to G. Pohl-Boskamp GmbH & Co.
KG ("Pohl-Boskamp") of Peace Naturals ("Peace") branded products is
now available for sale across retail locations throughout
Germany. Peace is a wholly-owned
licensed producer operated by Cronos, and Pohl-Boskamp is an
international pharmaceutical manufacturer with distribution into
over 12,000 pharmacies in Germany.
With over 82 million people, Germany is the largest federally legal
cannabis market in the world, and Pohl-Boskamp's distribution
network provides Cronos access to patients with insurance coverage
for medicinal cannabis.
"This marks a key milestone for Cronos by solidifying the
largest international distribution platform in the industry and
providing an unprecedented supply of high-quality medical cannabis
products to German patients," said Mike
Gorenstein, CEO of Cronos.
About Pohl-Boskamp
Pohl-Boskamp is a privately-owned business that has been active
in the international pharmaceutical market for 182 years with
commercialized products in more than 45 countries. Through close
collaboration with its partners abroad, Pohl-Boskamp focuses on
developing and marketing products that positively impact patients'
quality of life. It operates in numerous healthcare sectors
including pneumology, urology, parasitology, cardiovascular
diseases, gastroenterology, sleep disorders, and dermatology. For
more information visit https://www.pohl-boskamp.de/de/start/.
About Cronos Group
Cronos Group is a geographically diversified and vertically
integrated cannabis company that operates two wholly-owned Licensed
Producers ("LPs") regulated within Health Canada's Access to
Cannabis for Medical Purposes Regulations (the "ACMPR") and holds a
portfolio of minority investments in other Licensed Producers. The
Company's flagship LPs, Peace Naturals Project Inc. (Ontario) and Original BC Ltd. (British Columbia), are collectively situated
on over 125 acres of agricultural, licensed land. Cronos Group is
focused on building an international iconic brand portfolio,
providing patients with personalized care, and creating value for
our shareholders.
Forward-looking statements
This news release may contain "forward-looking information" and
"forward-looking statements" within the meaning of applicable
Canadian securities legislation. All information contained herein
that is not clearly historical in nature may constitute
forward-looking information. Forward-looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by management, are inherently subject
to significant business, economic and competitive risks,
uncertainties and contingencies that may cause actual financial
results, performance or achievements to be materially different
from the estimated future results, performance or achievements
expressed or implied by those forward-looking statements and the
forward-looking statements are not guarantees of future
performance. Except as required by law, Cronos Group disclaims any
obligation to update or revise any forward-looking statements.
Readers are cautioned not to put undue reliance on these
forward-looking statements. This news release contains information
obtained by Cronos Group from third parties. Cronos Group believes
such information to be accurate but has not independently verified
such information.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For more information, please visit
www.thecronosgroup.com.
SOURCE Cronos Group Inc.